Growth Metrics

Eli Lilly (LLY) Capital Expenditures Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 50.60%
Dec 31, 2025 41.14%
Sep 30, 2025 39.65%
Jun 30, 2025 43.19%
Mar 31, 2025 42.35%
Dec 31, 2024 35.59%
Sep 30, 2024 38.67%
Jun 30, 2024 38.50%
Mar 31, 2024 37.09%
Dec 31, 2023 22.12%
Sep 30, 2023 29.17%
Jun 30, 2023 18.95%
Mar 31, 2023 23.10%
Dec 31, 2022 2.46%
Sep 30, 2022 20.52%
Jun 30, 2022 10.86%
Mar 31, 2022 16.67%
Dec 31, 2021 -6.59%
Sep 30, 2021 8.16%
Jun 30, 2021 9.21%
Mar 31, 2021 14.25%
Dec 31, 2020 3.64%
Sep 30, 2020 7.52%
Jun 30, 2020 4.71%
Mar 31, 2020 6.49%
Dec 31, 2019 -4.40%
Sep 30, 2019 -2.37%
Jun 30, 2019 -1.17%
Mar 31, 2019 0.17%
Dec 31, 2018 -3.20%
Sep 30, 2018 1.23%
Jun 30, 2018 17.84%
Mar 31, 2018 8.42%
Dec 31, 2017 1.43%
Sep 30, 2017 5.93%
Jun 30, 2017 4.30%
Mar 31, 2017 5.27%
Dec 31, 2016 9.88%
Sep 30, 2016 5.30%
Jun 30, 2016 12.04%
Mar 31, 2016 8.76%
Dec 31, 2015 8.67%
Sep 30, 2015 10.76%
Jun 30, 2015 7.74%
Mar 31, 2015 8.56%
Dec 31, 2014 9.74%
Sep 30, 2014 11.24%
Jun 30, 2014 7.58%
Mar 31, 2014 5.17%